PH14802A - 4-amino-2-piperidino-quinazolines - Google Patents

4-amino-2-piperidino-quinazolines

Info

Publication number
PH14802A
PH14802A PH22500A PH22500A PH14802A PH 14802 A PH14802 A PH 14802A PH 22500 A PH22500 A PH 22500A PH 22500 A PH22500 A PH 22500A PH 14802 A PH14802 A PH 14802A
Authority
PH
Philippines
Prior art keywords
quinazolines
piperidino
amino
Prior art date
Application number
PH22500A
Other languages
English (en)
Inventor
Simon Fraser Campbell
John Christopher Danilewicz
Colin William Greengrass
Rhona Margaret Plews
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH14802A publication Critical patent/PH14802A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PH22500A 1978-05-18 1979-05-16 4-amino-2-piperidino-quinazolines PH14802A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2035178 1978-05-18

Publications (1)

Publication Number Publication Date
PH14802A true PH14802A (en) 1981-12-14

Family

ID=10144517

Family Applications (1)

Application Number Title Priority Date Filing Date
PH22500A PH14802A (en) 1978-05-18 1979-05-16 4-amino-2-piperidino-quinazolines

Country Status (30)

Country Link
US (1) US4243666A (xx)
JP (1) JPS554370A (xx)
AR (2) AR223487A1 (xx)
AT (1) ATA363379A (xx)
AU (1) AU512947B2 (xx)
BE (1) BE876297A (xx)
CA (1) CA1240325A (xx)
CH (1) CH643553A5 (xx)
CS (1) CS214796B2 (xx)
DD (1) DD143613A5 (xx)
DE (1) DE2919800A1 (xx)
DK (1) DK159079A (xx)
ES (2) ES480671A1 (xx)
FI (1) FI64589C (xx)
FR (1) FR2434162A1 (xx)
GR (1) GR72824B (xx)
HU (1) HU182562B (xx)
IL (1) IL57297A (xx)
IN (1) IN153045B (xx)
IT (1) IT1114222B (xx)
LU (1) LU81284A1 (xx)
NL (1) NL172157C (xx)
NO (1) NO791648L (xx)
NZ (1) NZ190465A (xx)
PH (1) PH14802A (xx)
PL (2) PL120651B1 (xx)
PT (1) PT69622A (xx)
SE (1) SE439306B (xx)
YU (2) YU115279A (xx)
ZA (1) ZA792390B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607034A (en) * 1979-10-29 1986-08-19 Mitsubishi Yuka Pharmaceutical Co., Ltd. Quinazoline derivatives and pharmaceutical composition thereof
JPS5962766U (ja) * 1982-06-30 1984-04-25 守田　智 小動物用給水器
GB8414518D0 (en) * 1984-06-07 1984-07-11 Pfizer Ltd Therapeutic agents
US5801195A (en) * 1994-12-30 1998-09-01 Celgene Corporation Immunotherapeutic aryl amides
US6248888B1 (en) 1997-11-14 2001-06-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of terazosin hydrochloride dihydrate
CA2434934A1 (en) * 2001-01-18 2002-07-25 Takeda Chemical Industries, Ltd. Process for preparation of benzylpiperidine compounds
US6746460B2 (en) * 2002-08-07 2004-06-08 Satiety, Inc. Intra-gastric fastening devices
CA2543710A1 (en) * 2003-11-03 2005-05-12 Warner-Lambert Company Llc Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
TW200831497A (en) * 2006-10-12 2008-08-01 Epix Delaware Inc Carboxamide compounds and their use
US8642758B2 (en) * 2007-04-04 2014-02-04 Cipla Limited Process for preparation of erlotinib and its pharmaceutically acceptable salts
US8569282B2 (en) 2007-12-11 2013-10-29 Cytopathfinder, Inc. Carboxamide compounds and their use
WO2010054968A1 (en) * 2008-11-14 2010-05-20 F. Hoffmann-La Roche Ag Quinazoline derivatives as nk3 receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
FR2321890A1 (fr) * 1975-08-26 1977-03-25 Synthelabo Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment
DK140695C (da) * 1976-05-07 1980-05-12 Synthelabo Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf

Also Published As

Publication number Publication date
CS214796B2 (en) 1982-05-28
ATA363379A (de) 1983-05-15
PL223844A1 (xx) 1981-01-02
GR72824B (xx) 1983-12-06
IL57297A (en) 1983-02-23
LU81284A1 (fr) 1980-12-16
PL215626A1 (xx) 1980-08-25
AU4710179A (en) 1979-11-22
DK159079A (da) 1979-11-19
NL172157C (nl) 1983-07-18
CH643553A5 (de) 1984-06-15
ES480671A1 (es) 1980-08-16
NO791648L (no) 1979-11-20
FI64589C (fi) 1983-12-12
AR223487A1 (es) 1981-08-31
NL7903853A (nl) 1979-11-20
ES8101584A1 (es) 1980-12-16
HU182562B (en) 1984-02-28
PL121158B1 (en) 1982-04-30
FI791562A (fi) 1979-11-19
YU256382A (en) 1983-04-30
US4243666A (en) 1981-01-06
DD143613A5 (de) 1980-09-03
FR2434162A1 (fr) 1980-03-21
IT1114222B (it) 1986-01-27
CA1240325A (en) 1988-08-09
FR2434162B1 (xx) 1983-04-22
JPS554370A (en) 1980-01-12
IL57297A0 (en) 1979-09-30
ZA792390B (en) 1980-07-30
BE876297A (fr) 1979-11-16
NL172157B (nl) 1983-02-16
SE439306B (sv) 1985-06-10
SE7904358L (sv) 1979-11-19
YU115279A (en) 1983-04-30
PL120651B1 (en) 1982-03-31
NZ190465A (en) 1981-05-01
ES488210A0 (es) 1980-12-16
AU512947B2 (en) 1980-11-06
DE2919800A1 (de) 1979-11-22
IN153045B (xx) 1984-05-26
JPS5623992B2 (xx) 1981-06-03
PT69622A (en) 1979-06-01
FI64589B (fi) 1983-08-31
AR224784A1 (es) 1982-01-15
IT7922720A0 (it) 1979-05-16

Similar Documents

Publication Publication Date Title
CS520079A2 (en) Nosna soustava snimaci hlavice
DE2967509D1 (en) Skin-equivalent
BG27580A1 (en) Two- poled pelvis- thight articulation- set
CS74479A2 (en) Omezovac nadmerne proudove vodivosti televizni reprodukcni obrazovky
GB2027917B (en) Shutter-diaphragm
CS333379A2 (en) Upinaci zarizeni
GB2013938B (en) Servocontrollers
CS615079A2 (en) Zpusob vyroby inhibitoru enzymu
PH14802A (en) 4-amino-2-piperidino-quinazolines
CS613879A2 (en) Zpusob vyroby fenylchinolizidinu
CS846479A2 (en) Tkaci stroj
CS290179A2 (en) Plynova vybojka
GB2015278A (en) Straight-through-repeater
GB2014109B (en) Exavators
EP0004713A3 (en) Twinski
GB2014996B (en) Arylacetamidocephalosporins
EG13808A (en) Carbamoyl-oximes
GB2012937B (en) Refigerators
GB2013592B (en) Play-vehicle
GB1550031A (en) Hairdriers
GB1558045A (en) Drumtensioning
CS686179A2 (en) Zpusob vyroby fenylchinolizidinu
GB1555634A (en) Sportsballs
CS556679A2 (en) Zpusob vyroby derivatu chlorambucilu
CS839779A2 (en) Zpusob vyroby benzimidazol-karbamatu